- All sections
- A - Human necessities
- A61B - Diagnosissurgeryidentification
- A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
Patent holdings for IPC class A61B 5/1486
Total number of patents in this class: 2460
10-year publication summary
|
202
|
170
|
279
|
200
|
250
|
265
|
239
|
201
|
175
|
140
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DexCom, Inc. | 1765 |
441 |
| Abbott Diabetes Care Inc. | 2075 |
359 |
| Medtronic MiniMed, Inc. | 1782 |
272 |
| Roche Diabetes Care, Inc. | 1495 |
131 |
| F. Hoffmann-La Roche AG | 7800 |
74 |
| Roche Diabetes Care GmbH | 689 |
60 |
| Ascensia Diabetes Care Holdings AG | 600 |
58 |
| The Regents of the University of California | 20842 |
38 |
| PHC Holdings Corporation | 708 |
35 |
| ARKRAY, Inc. | 857 |
29 |
| Bionime Corporation | 144 |
26 |
| California Institute of Technology | 4037 |
23 |
| Allez Health Inc. | 44 |
23 |
| One Health Biosensing Inc. | 45 |
22 |
| PercuSense, Inc. | 43 |
21 |
| Biolinq, Inc. | 144 |
19 |
| Terumo Kabushiki Kaisha | 5849 |
18 |
| Medtrum Technologies Inc. | 364 |
17 |
| Uxn Co., Ltd. | 38 |
17 |
| Verily Life Sciences LLC | 940 |
14 |
| Other owners | 763 |